Search results
Results from the WOW.Com Content Network
The primary endpoint of this study was the 1-year survival rate after BNCT, which was 79.2%, and the median overall survival rate was 18.9 months. Based on these results, it was concluded that c-BNS BNCT was safe and resulted in increased survival of patients with recurrent gliomas.
Furthermore, ionizing radiation above a dose of around 50-100 millisievert exposure has been shown to statistically begin increasing a person's chance of dying of cancer sometime in their lifetime over the normal unexposed rate of c. 25%, in the long term, a heightened rate of cancer, proportional to the dose received, would begin to be ...
For men over 64 with prostate cancer limited to the pelvis, using fewer, larger doses of radiation (hypofractionation) results in similar overall survival rates. [28] The risk of dying from prostate cancer or having acute bladder side effects may be similar to that of longer radiation treatment. [28]
Radiation hormesis is the conjecture that a low level of ionizing radiation (i.e., near the level of Earth's natural background radiation) helps "immunize" cells against DNA damage from other causes (such as free radicals or larger doses of ionizing radiation), and decreases the risk of cancer. The theory proposes that such low levels activate ...
Increased Risk of Solid Cancer with Dose for A-bomb survivors, from BEIR report.Notably, this exposure pathway occurred from essentially a massive spike or pulse of radiation, a result of the brief instant that the bomb exploded, which while somewhat similar to the environment of a CT scan, is wholly unlike the low dose rate of living in a contaminated area such as Chernobyl, where the dose ...
RBEs can be used for either cancer/hereditary risks or for harmful tissue reactions (deterministic) effects. Tissues have different RBEs depending on the type of effect. For high LET radiation (i.e., alphas and neutrons), the RBEs for deterministic effects tend to be lower than those for stochastic effects. [1]
BEIR III 1980: “The Effects on Populations of Exposure to Low Levels of Ionizing Radiation” BEIR IV 1988: “Health Effects of Radon and Other Internally Deposited Alpha-Emitters” BEIR V 1990: “Health Effects of Exposure to Low Levels of Ionizing Radiation” BEIR VI 1999: “The Health Effects of Exposure to Indoor Radon”
Brachytherapy is a type of radiotherapy, or radiation treatment, offered to certain cancer patients. There are two types of brachytherapy – high dose-rate (HDR) and low dose-rate (LDR). LDR brachytherapy is the one most commonly used to treat prostate cancer. It may be referred to as 'seed implantation' or it may be called 'pinhole surgery'. [1]